Webinar | Directed Evolution of T7 RNA Polymerase & a Novel Synthetic Self-amplifying RNA System

01

CEO of Molefuture Biotech and Director of Yeasen Enzyme Evolution R&D Center

As Cofounder & CEO of Molefuture since 2023, Dr. Liu brings over a decade of leadership and innovation in the biotech industry, specializing in enzyme evolution. Most recently, she served as the Senior Director at Yeasen Biotechnology, where she advanced enzyme technologies for research and applications in IVD, NGS, and pharmaceuticals. Previously, Dr. Liu served as Technology Manager at Wilmar (Shanghai) Biotechnology R&D Center, focusing on innovative enzymatic processes in the oil and fat industry. Dr. Liu's early career was marked by her role as Associate Scientist and Innovation Manager at DSM Biotechnology Centre China, where she was at the forefront of enzyme application innovation in the food industry. She holds a Ph.D. in collaboration between East China University of Science and Technology and the California Institute of Technology.

02

Director of mRNA & Plasmid Department, GenScript Biotech

Dr. Kangming Chen is currently the head of mRNA & Plasmid Department in GenScript Biotech. He received a B.S. in Biological Science and a M.S. in Ecology from the Lanzhou University in 2005 and 2008 respectively. Then he began his Ph.D. in South Dakota State University where he studied molecular microbiology with his dissertation advisor Dr. Ruanbao Zhou. His dissertation research focused on Regulated Intramembrane Proteolysis in cyanobacteria. He received his Ph.D. in Biology & Microbiology in the summer 2014. Afterwards, Dr. Chen began working under the supervision of Dr. Philip Hardwidge at Kansas State University, where he researches how Citrobacter rodentium type III effector NleB affecting the interferon signaling pathway. In 2016, Dr. Chen joined GenScript as a senior scientist and researched on large genome fragment synthesis. In 2022, he became the leader of mRNA & Plasmid team focusing on Plasmid preparation, IVT mRNA synthesis and LNP delivery. So far, Dr. Chen has published more than 15 peer-reviewed papers including a recent (2023) co-authored Nature paper titled A Swapped genetic code blocks viral infections and gene transfer. https://pubmed.ncbi.nlm.nih.gov/36922599/